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ABSTRACT

AN INVESTIGATION OF CHANGES IN DIABETES TRENDS AFTER THE AFFORDABLE
CARE ACT

By
BLAIR CHRISTENSEN

4/15/18

INTRODUCTION: Diabetes Mellitus (DM) is one of the fastest growing and most costly
chronic diseases in the United States. DM is severely underdiagnosed, resulting in increased
complications, costs, and mortality. Primary goals of the Affordable Care Act (ACA) were to
increase health insurance coverage and access to care, and to improve chronic disease outcomes.
However, the effects of the legislation have not been widely studied, particularly the relationship
between proper diabetes diagnosis and a variety of health related factors.
AIM: Determine the relationship between DM prevalence and under-diagnosis, to healthcare
utilization, usual source of care, insurance, type of insurance, and population characteristics have
changed since the implementation of the ACA.
METHODS: Data collected between 2005 and 2016 in the National Health and Nutrition
Examination Survey were used for this work. The Andersen behavioral health model was used as
a theoretical framework and selection of study variables. Descriptive statistics and advanced
statistical modeling techniques were applied. Distinct multilevel models were used to model the
logit of the probability of DM and the logit of the probability of a proper DM diagnosis each as a
function of study variables with an indicator of pre- or post-ACA included as a fixed effect.
Marginal models are multilevel models that apply population averaged estimates for parameters.
Marginal models were specified to account for clustering by time, and generalized estimating
equations used to estimate model parameters. The quasi-likelihood under the null (QIC) statistic
was estimated for model comparisons. The SAS Software System was used for data analysis and
the level of significance set at .05.
RESULTS: The sample consisted of 31,225 participants, with half pre-ACA (n=15,612) and
half post-ACA. Females comprised 51.64% of the study sample with 43.50% White, 25.82%
Hispanic, and 20.65% Black and a mean (standard deviation) age of 49.3 (17.9) years. About
11.45% of those in the Pre ACA period had a diagnosis of DM, while 13.5% of those in the Post
ACA period had a diagnosis of DM. The percentage of uninsured was 23.95% in the Pre ACA
i

period and 20.69% in the Post ACA time period. The prevalence of undiagnosed DM patients
was 26.7% before the ACA, and 21.3% after. A multilevel model with DM status as the
dependent outcome showed that sex (females vs males: OR=0.83, 95%CI=0.78,0.89,p =.02),
USC (yes vs no: OR=1.28, 95%CI=1.03,1.59, p=.03), health insurance (yes vs no: OR=1.21,
95%CI=1.17,1.26, p =.02), and education level(college graduate vs less than high school:
OR=0.79, 95%CI=0.64,0.97, p=.05, high school graduate vs less than high school: OR=0.97,
95%CI=0.93,1.03, p=.05) were significantly associated with presence of DM. Participants were
more likely to have their DM properly diagnosed after the ACA: in the final multivariable
multilevel model, only ACA time period had a significant effect on correct DM diagnosis
(OR=1.51, 95%CI=1.24,1.85, p=.04).
CONCLUSIONS: Although prevalence of DM has increased in recent years, under-diagnosis is
less of an issue after the ACA. In the multivariable model comparing DM status (having the
disease) to selected covariates, sex, health insurance, education, and USC were related to DM
status. The ACA time period had no significant relationship with DM status in the multivariable
model. However, in the multivariable model for correctly diagnosed DM, ACA time period was
the only independent variable that had a significant association with correct DM diagnosis.
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Introduction
Diabetes Mellitus (DM) is one of the fastest growing and most impactful chronic diseases
in the United States and encompasses several different diseases, all characterized by issues in
proper insulin manufacture and utilization and resulting high blood glucose levels[1] [2].
Chronic diseases have fast been replacing infectious diseases as the primary public health issues
of interest in developed countries. Those afflicted suffer from not only diminished life
expectancies but also a decrease in quality of life, and a high burden of expenses and time that
must be devoted to managing the disease. When a healthcare system is ill-equipped to handle the
regular maintenance and upkeep of the disease, it is reflected in poor self-care, complications,
and worsened outcomes, not to mention an increased financial burden at both the individual and
the system-level.
DM is also severely underdiagnosed. Nearly a quarter of those with DM have not been
diagnosed by a doctor[1]. An unknown or late-stage DM diagnosis results in a lack of self-care
and awareness, manifesting in increased complications, costs, and mortality[3]. Someone who
has DM but has not been formally diagnosed by a doctor is known as a “missed patient”.
One of the primary goals of the Affordable Care Act (ACA) was to increase the
prevalence of health insurance and access to care, and to improve chronic disease outcomes. The
rationale behind this is that broadened insurance coverage in the population and improved ease
of access should lead to an increase in utilization, which prior research dictates should improve
healthcare outcomes. Since the legislation is still relatively new and untested, there is no
definitive answer as to whether DM-related outcomes have improved.

1

The National Health and Nutrition Examination Survey (NHANES) contains information
on socio-demographic, behavioral, and laboratory values, and is designed to be representative of
the entire US population[4]. NHANES provides an ideal data source for an adapted Andersen
model examining health behaviors and DM outcomes as they relate to the ACA. This adapted
model can be used as a starting point for multivariate analysis and the eventual construction of a
multilevel model taking the clustering by survey cycle into account.
This study will address not only how DM outcomes might have changed following the
implementation of the ACA but also how the relationship between insurance status (type and
presence or absence of), utilization, and Usual Source of Care(USC) with DM outcomes may
have changed along with the shift in the regulatory and policy environment. It will also
determine if there has been a shift in patterns of diagnosis since the passage of the ACA.
Previous studies (detailed below) have usually examined only one of these factors’ relationship
to a health outcome, rather than how they might interact to result in an outcome. For DM, disease
status is also usually only assessed by clinical diagnosis, which becomes problematic in
underserved populations that do not utilize healthcare services- a diagnosis is not the best
reflection of actual disease status in these instances. In this study, a HbA1c blood test is used to
determine if an individual has DM. By employing a multi-level modeling approach to study time
periods before and after the passage of the ACA, the disregard for the clustering of the data
found in many prior studies will be remedied.
Disentangling the relationship between policy, healthcare behaviors, and DM outcomes is
important for several reasons. Better understanding the impact of healthcare reform on chronic
disease outcomes could help to improve and shape future legislation. An idea of the true
relationship between complicated sets of healthcare behaviors and causes can also guide
2

healthcare recommendations and improve outcomes for diabetics. Understanding these
relationships for DM could also help to inform decisions about other chronic diseases.
The questions this study seeks to answer are:
I.

Controlling for demographic characteristics, has the association between
insurance status and DM changed since the passage of the ACA?

II.

Controlling for demographic characteristics, has the association between
healthcare utilization and DM changed since the passage of the ACA?

III.

Controlling for demographic characteristics, has the association between having a
USC and DM changed since the passage of the ACA?

IV.

What demographic characteristics are associated with being a “missed patient”
and have the associations changed since the passage of the ACA?

V.

Has the prevalence of “missed patients” changed since the passage of the ACA?

Literature Review
Epidemiology of DM
DM encompasses several different diseases, all characterized by issues in proper insulin
manufacture and utilization and resulting high blood glucose levels[1]. Type 2 DM is the most
common form and can be defined as an acquired intolerance to insulin due to dietary and
lifestyle factors. The prevalence of DM has been increasing and is projected to continue
increasing[2]. DM has become a public health crisis, with 30.3 million diabetics in the US,
nearly a quarter of which (23.8%) are estimated to be undiagnosed[5]. The low diagnosis rates
are thought to be consequence of the fact that many diabetics do not enter the healthcare system
until they begin suffering from complications from their disease[1]. Type 2 DM is diagnosed
3

using the HbA1c test, with results greater than or equal to 6.5% indicating controlled DM and
values above 8% indicating uncontrolled DM[6]. The HbA1c is considered the gold standard in
diagnosing DM[1]. DM patients spent more than twice as much on medical expenditures and
non-diabetics[7]. Diabetics have a high burden of maintenance costs, which include regular
doctor visits, medication, education programs, specialized diets, and other assorted items[8]. In
addition to the maintenance costs associated with DM, the potential of comorbidities and
complications from mismanagement and the natural progression of the disease also impose a
massive burden on the public health system[8-10]. Uncontrolled DM can lead to foot ulcers and
amputations, eye deterioration, kidney disease, cardiovascular disease, mobility issues, high
cholesterol, and an overall reduction in both quality of life and overall life span[1]. The
estimated cost from DM in 2012 was $245B, not including the undiagnosed burden and unpaid
care[7].
Health Behaviors and Outcomes
Andersen’s Behavioral Model of Health Utilization was first proposed in the early 1970’s
as a way to study and predict individual usage of health services. [11] The next update to the
model included external and environmental factors, along with incorporating user satisfaction
with services [12]. The current iteration of the model includes four primary spheres of influence,
all of which connect and create a kind of feedback loop: Environment, Population
Characteristics, Health Behavior, and Outcomes.[13, 14] This construction allows for the
examination of the relationship between complicated sets of healthcare behaviors, demographic
characteristics, policy and healthcare system changes, and outcomes, both quantitative and
qualitative. The Andersen model is generally accepted as the best framework when analyzing
complex and nuanced healthcare concepts, like utilization and access to care [15-17].
4

Environmental factors can include regulatory environment and policy changes in the health care
system and time could be incorporated as a variable. Population characteristics are divided into
three distinct sections: Predisposing (including Demographic and Social attributes), Enabling
(including Financial and Accessibility factors) and Need. Need-based characteristics are rooted
more in perception of need than in actual physical need, including perceived health status and
previous diagnosis of a disease[13]. Using Andersen’s model allows for a better understanding of
health behavior and utilization and the inclusion of the necessary characteristics and external
factors to fully describe the relationship.
Factors Associated with DM-outcomes
It has been long established that health outcomes and behavior exhibit distinct racial and
cultural disparities. Minorities, smokers, those of lower Socioeconomic Status(SES) and those
with less education are more likely to have DM[18]. DM development and outcomes, along with
management of care, are also associated with socioeconomic factors and behaviors[19].
Perception of health status and denial about health problems is a common reason why health
services might not be fully utilized or chronic disease care left unmanaged[20]. There are racial
and socioeconomic class differences in DM screening diagnosis accuracy[21]. Increased
utilization of health services, medication adherence and disease management were shown to be
associated with the perception of personal health status [22]. An official diagnosis of DM did not
seem to influence health behaviors or perception of health status[22]. A 2009 study found that a
significant proportion of Diabetics (around 10%) had no health insurance coverage, usually due
to high premium costs[23].
Health Services Utilization is a multifaceted and difficult to quantify concept. It can be
defined as “the measure of the population’s use of the health care services available to them,”
5

and can be an indicator of “how efficiently a health care system produces health in a
population”[24]. Utilization is a behavior pattern determined by demographic characteristics, like
ethnicity, and external environmental factors, like policy, the effect of which can be measured in
discrete outcomes. Utilization has been associated with increased mortality in high risk
groups[25], but this association is not causal and, in general, utilization is associated with
improved preventative care and health behaviors[26]. Insurance coverage increases the
likelihood of utilizing care[27].
Usual Source of Care(USC) is defined as “a particular doctor’s office, clinic, health
center, or other place one goes to if one is sick or needs advice about health.”[28] The effects of
having a USC have been a source of debate in the literature for some time now. One theory is
that a USC is determined by utilization and only indirectly affects doctor visit frequency, while
the other is that the lack of a USC serves as a barrier to access, directly minimizing the amount
of doctor visits and utilization[29]. It has been established that not having a USC can limit
continuous utilization of services. This is particularly important for DM care, which requires
consistent monitoring and attention[30, 31]. Having a USC also serves as a proxy for access to
the overall healthcare system and is associated with improved outcomes and preventative
care[30, 32]. A USC was found to be a better predictor of access to care than whether or not a
patient was insured[33].
Insurance coverage alone does not ensure utilization of care[34-38]. A 2012 study found
that a USC was more important than health insurance coverage in determining utilization and
outcomes; children with both a USC and insurance had better outcomes than those with only
insurance. Having only a USC was more beneficial than only having insurance[34]. While
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insurance does not ensure access, being insured has been found to be associated with a higher
quality of care and improved access[39].
Type of insurance has also been shown to effect health outcomes and perceptions. Less
physicians accept new patients with public insurance than private, and certain physicians do not
accept any public insurance coverage[40, 41]. Medicaid users report feeling more stigmatized
and have worse access and health outcomes than those with private insurance [42]. Private health
insurance coverage has also been found to be correlated with higher incomes and previous health
status, and public insurance programs tend to decline in per capita resources and quality of care
over time[43].
Having DM is associated with physician quality and type of insurance plan, and DM
patients with self-stigma issues had worsened outcomes. [44-46] Poor glycemic control and
outcomes in DM patients were associated with cost and lack of insurance, isolation, and
difficulty accessing care[47]. A lack of access and lack of insurance were found to be
associated with a delay or complete failure to have DM diagnosed, known as being a “missed
patient”. [48]
Impact of the ACA
The passage of the Patient Protection and Affordable Care Act (ACA) was supposed to
provide renewed focus on lowering barriers to access and expanded, affordable insurance
coverage. While research has been done on the effects of the legislation, many studies are
contradictory, small, or focused more in the realm of health economics[49-52]. The ACA
certainly increased insurance coverage, with the lowest ever amounts of uninsured Americans. It
is estimated that the number of those without coverage was reduced by around 20 million due to
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the passage of the ACA, and the effects were present in the entire population, regardless of age,
race, gender, or level of education[53]. Studies conducted after the implementation of the ACA
have found improved access to care and higher percentages of insured, compared to before the
legislation was passed[26]. In Medicaid expansion states, DM outcomes were greatly improved
and hospitalizations were minimized. [54] Diabetic adults without insurance utilize care less and
have less access to care. The increased access and coverage provided by the ACA has increased
the utilization of healthcare services among diabetics, possibly leading to better overall health
conditions and lower incidence of DM complications.[55]
In those newly insured due to the ACA, having a USC was more common, preventative
visits, glucose testing and utilization of services increased, and there was a marked improvement
in self-reported health status[56]. Socioeconomic status is linked to utilization, and health status
must be considered when analyzing utilization across different socioeconomic classes[57, 58]. In
the past, major policy initiatives and shifts in the regulatory environment have been shown to
influence utilization[59].
Gaps in the Literature
There has been no research comparing the relationship between utilization, access,
insurance and blood glucose level outcomes before and after the implementation of the
Affordable Care Act. This study will address not only how DM outcomes might have changed
following the implementation of the ACA but also how the relationship between insurance status
(type and presence or absence of), utilization, and access with DM outcomes may have changed
along with the shift in the regulatory and policy environment. Among studies that have examined
one of these factors relationship to DM outcomes, none have used a multilevel modeling
approach or examined a wide array of NHANES data. Failing to take the clustering of the data
8

into account in this way results in biased parameter estimates and ultimately leads to incorrect
conclusions.
There has also been little research on missed patients, and nothing assessing their
prevalence comparing regulatory environment. Studying underdiagnosis is fundamentally
difficult, because the true disease status must be determined for those without a diagnosis,
usually through a blood test. This is much more invasive and resource-intensive than simply
filling out a questionnaire with disease status. Most previous studies have not analyzed DM
status as a function of a HbA1c test. The problem of under-diagnosis is remedied, as the results
of this test are not dependent on having been previously diagnosed with the disease. Previous
studies examining more than one cycle of NHANES have also often neglected to take the
clustering of data by year into account.
Methods
Data source
The National Health and Nutrition Examination Survey (NHANES) is completed in
continuous 2-year cycles by the Centers for Disease Control and was created to examine the
nutritional and health status of all non-institutionalized adults and children in the United States.
The survey sample contains around 5000 people each year from 15 United States counties and is
designed to be nationally representative. NHANES oversamples Blacks, Hispanics, and those
older than 60 years of age, and the examination portion is more extensive in older participants.
The interview portion gathers information on socioeconomic, dietary, demographic, and health
questions. This interview is conducted in the participants home, in a variety of different
languages. There is also an examination portion, where medical, dental, and physical aspects are

9

measured; laboratory tests are also included. This portion of the survey takes place through
participant visits to mobile clinics that travel with NHANES [1]. One unique aspect of the survey
is that it collects biological samples along with questionnaire and demographic data. An HbA1c
is included in the laboratory data, and has been shown as a useful and accurate indicator of DM
status and previously undiagnosed DM, particularly in a single-visit setting[60]. This provides a
unique opportunity when studying DM outcomes- the usual under-diagnosis is a negligible factor
and does not need to be considered. NHANES also includes information on demographics, use of
health services, insurance coverage and type, and USC (USC). Socio-demographic
characteristics and general healthcare questions were utilized from the NHANES questionnaires.
Three two-year cycles (2005-2006, 2007-2008, and 2009-2010) represented the time period
before the ACA, and three cycles (2011-2012, 2013-2014, and 2015-2016) for after the ACA.
Study population
The study population captured by NHANES are United States residents of all ages who
are not institutionalized, living in nursing homes, living abroad, or in the armed forces.
Study sample
To create the sample, the entire United States (including Alaska and Hawaii) is divided
into 15 groups, and a single county is selected from each group. Then around 20 smaller
subdivisions are selected from each county. Roughly 30 households are selected from each
subdivision, and all household members are interviewed. A random algorithm then selects a
random number of the participants in each household[4]. Only individuals who had participated
in the relevant questionnaires and had a measurement for the response variable were included in
the analysis. Individual observations for some questions could still be missing. Only respondents
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age 20 or above were included in the final dataset. Table 4.1 includes the measurements for the
study sample by pre- and post-ACA.
Dependent Variables
The traditional HbA1c test findings were used to create the dependent variable. The
continuous measured value represented the percentage of glycated hemoglobin present in the
blood. For the analysis, the outcome was created by dichotomizing HbA1c test with a cutoff of
6.5% or above indicating DM[1]. Only those with non-missing values for the outcome variable
were selected for the sample(n=31225). “Missed Patient” status was determined by creating a
new variable from only those above the 6.5% cutoff and whether they had previously received a
DM diagnosis from a doctor.
Independent Variables
Utilization and access were operationalized in this study as the amount of doctor visits in
the last 12 months and whether an individual had a USC, defined as “a routine place to go for
healthcare or when you are sick”. Frequency of doctor visits was an ordinal variable with the
categories: 0 visits, 1 visit, 2-3 visits, 4-9 visits, 10-12 visits, and 13 or more visits. General
health condition was recoded into a three-category variable: Poor/Fair, Average, and
Good/Excellent. Insurance status and DM diagnosis were binary variables. Insurance type was
recoded into Private, Medicare, Medicaid/Medigap, Other, and None. Education was recoded
into a three-category variable, less-than High school, High school graduate, and College graduate
or above. Income was assessed using the income to poverty level ratio. Race/Ethnicity was
broken into 4 categories: Hispanic, White, Black, and other.
Statistical Analysis
11

The SAS Software System was used for all the statistical analyses. The level of
significance was set at .05. Although NHANES is a complex multistage weighted survey,
previous studies have shown that the difference in error that comes from discounting them may
be potentially insignificant and possibly may not greatly alter inferences made [61]. The methods
for including survey weights in a multilevel modeling scheme are also complex. The SAS
Software System multilevel modeling procedures to not allow for simultaneously fitting
multilevel models and accounting for complex sampling weights. Since a primary interest was in
accounting for the clustering within survey year to apply multilevel models, these were used and
survey weights not accounted for in analyses presented here. The caveats and possible
repercussions of this choice are included in the discussion.
In repeated measures or clustered longitudinal data, the assumption of independence of
observations necessary for many modeling techniques (Logistic Regression, ANOVA) is
violated[62]. In this dataset, there are two levels of variables. The first level is individual
measurements and the second level is the survey year. Ignoring the clustering of observations
leads to biased estimation and incorrect standard errors. Multilevel modeling techniques account
for clustering or grouping of data. Marginal models are a semi-parametric method that averages
the random effects of the second-level variable to provide a population-averaged coefficient,
rather than individual-level estimates. This approach allows meaningful conclusions to be drawn.
Marginal models use Generalized Estimating Equations(GEE) to estimate parameters [63]. A
Marginal Mixed model was constructed for each Bivariate comparison and for the selected
multivariable model.
Variables were selected for inclusion in the final model using a combination of a datadriven and a theory driven approach. A theoretical relationship between the outcome, health
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behavior, population characteristics and environment was assessed by creating a modified
Andersen Behavioral model of Healthcare Utilization. This model was used to select variables to
be tested for inclusion in the model from the NHANES dataset. Eight possible models were
identified from the constructed behavior model and tested. Quasi likelihood under the
Independence Model Criterion(QIC) was then used to select the correlation structure and the
variables for inclusion in the final model[64]. Although GEE is robust to misclassification of the
correlation structure, testing for correct structure is efficient and desirable. The structures
compared in this work were Independence, Compound Symmetry, and First-order
Autoregressive (a steady and equivalent heterogeneity of variance). Type of insurance was
assessed only with a bivariate model since health insurance status was already considered in the
model and to avoid multicollinearity issues. Bivariate comparison models are also included for
all variables, which allows full examination of how associations are affected by the adjustments
in the final model.
For the analysis of missed patients, a subset of the data with only DM patients was
created(n=3394). Descriptive frequencies were tabulated, stratified by missed patient status and
before or after ACA time-period. Adjusted and crude by-characteristic Odds Ratio point
estimates and 95% Confidence Intervals were calculated and p-values reported for a final
multivariable model.
Results
Descriptive Statistics for DM
Table 4.1 includes the descriptive statistics of socio-demographic, health behavior, and
DM in persons 20 years and older in NHANES 2005-2010 (before time period or Pre ACA) and
NHANES 2011-2016(after time period or Post ACA). The overall study sample consisted of
13

31,225 participants, with half pre-ACA (n=15,612) and half post-ACA. Females comprised
51.64% of the study sample with 43.50% White, 25.82% Hispanic, and 20.65% Black and a
mean (standard deviation) age of 49.3 (17.9) years. About 11.45% of those in the Pre ACA
period had a diagnosis of DM, while 13.5% of those in the post ACA period had a diagnosis of
DM. In the Pre and Post ACA periods respectively, 1.91% and 2.56% had missing values for
DM diagnosis. The percentage of uninsured decreased from 23.95% in the Pre ACA period to
20.69% in the Post ACA time period. Overall, less than a tenth of a percent had a missing value
for insurance. In the overall sample, 25.91% had less than a high school education, 51.52% had a
high school diploma, and 22.48% were college graduates or higher. Only a tenth of a percent
were missing education level. Levels of Utilization were constant across both time periods.
Overall, 16.52% had no doctors visits in the last year, 17.59% had 1 doctors visit in the last year,
27.07% had 2-3 visits, 25.02% had 4-9 visits, 6.44% had 10-12 visits, and 7.27% had 13 or more
visits. Less than a tenth of a percent of respondents had a missing value for utilization. Pre ACA
10.53% had DM, while Post ACA 12.16% had DM. Pre ACA, 7.83% had Medicaid or Medigap,
18.01% had Medicare, 23.96% had no insurance, 38.8% had private insurance, and 11.16% had
some other form of insurance. In the Pre ACA period, 0.22% had a missing value for insurance
type. Post ACA, 11.43% had Medicaid or Medigap, 15.22% had Medicare, 20.75% had no
insurance, 37.80% had private insurance, and 14.3% had some other form of insurance. In the
post ACA period, 0.55% had missing values for insurance type. USC was constant across the
time periods, with 84.68% having a USC Pre ACA and 83.72% having a USC Post ACA. There
were no responses missing for USC. Health condition also remained constant from Pre to Post
ACA, with 39.37% reporting poor/fair health, 36.41% reporting average health, and 24.22%
reporting good/excellent health. Overall, less than a tenth of a percent of responses were missing
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for health condition, with 0.06% missing from Pre ACA and 0.09% missing from Post ACA. The
distribution across sexes remained constant across the time periods, with slightly more females
than males (51.64% and 48.36%, respectively). The distribution of ethnicities across the two
time periods were slightly different, and there were no missing responses for ethnicity. Pre ACA,
19.32% of respondents were black, 27.13% Hispanic, 48.94% White, and 4.61% Other. Post
ACA, 21.98% of respondents were Black, 24.52% Hispanic, 38.06% White, and 15.44% Other.
Pre ACA, 18.27% of respondents were below the poverty line, with 8.46% missing a response,
while Post ACA 20.62% were, with 9.32% missing a response. The mean age in years Pre ACA
was 49.50 and 49.13 Post ACA.
Associations with Diabetes
Time-period(Pre or Post ACA), age, sex, utilization, USC, health condition, insurance,
education, ethnicity, and income were selected for inclusion in the final multivariable multilevel
model (Table 4.2), and an independent correlation structure was chosen, with
QIC=16773.27(Table 4.3).
The final multivariable multilevel model of DM status (table 4.4) showed that the timeperiod after the ACA was unrelated to DM in both the bivariate (OR=1.77,
95%CI=0.99,1.4,p=.07) and the adjusted model (OR=1.90, 95%CI=1.1,1.33,p=.09). Those with
health insurance were significantly more likely to have DM in the unadjusted analysis (OR=1.51,
95%CI=1.44,1.58,p<.0001). Once adjusting for covariates, those with DM were also
significantly more likely to have health insurance (OR=1.21, 95%CI=1.17,1.26, p =.02). Those
with Medicaid/Medigap (OR=2.17, 95%CI=1.86,2.53,p<.0001), Medicare (OR=2.79,
95%CI=2.64,2.96,p<.0001), and Other (OR=1.5, 95%CI=1.31,1.7,p<.0001) types of insurance
were more likely to have DM, compared to those with a private insurance plan. Income above
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the poverty level was not related to DM outcomes in the adjusted model (OR=0.97,
95%CI=0.86,1.1,p=.28) but was found to be significant in a simple bivariate analysis (OR=0.76,
95%CI=0.65,0.89,p=.0007). Those with a high school education had lower odds of having DM
(OR=0.60, 95%CI=0.58,0.68,p<.0001), and this result remained significant in the adjusted model
(OR=0.97, 95%CI=0.93,1.03,p=.05). College graduates consistently had significantly lower odds
of having DM in both the multivariable (OR=0.79, 95%CI=0.64,0.97,p=.05) and bivariate
(OR=0.39, 95%CI=0.36,0.42, p<.0001) model. Compared to Whites in a bivariate model, Blacks
(OR=1.88, 95%CI=1.63,2.16,p<.0001), Hispanics (OR=1.72, 95%CI=1.52,1.97,p<.0001), and
those of Other ethnicity (OR=1.35, 95%CI=1.18,1.56,p<.0001) had higher odds of having DM.
Compared to Whites in the multivariable model, Blacks (OR=1.88, 95%CI=1.68,2.12,p=.11),
Hispanics (OR=1.99, 95%CI=1.75,1.2.26,p=.11), and those of Other ethnicity (OR=1.85,
95%CI=1.66,2.05,p=.11) did not have significantly higher odds of having DM.
Compared to no visits, having one doctor visit in the past year was not associated with
increased odds of having DM in both the bivariate (OR=1.03, 95%CI=0.99,1.07) and the
multivariable (OR=1.03, 95%CI=0.93,1.14,p=.31) model. In the bivariate model, having DM
was correlated with increased doctor visits, ranging from 2-3 visits (OR=1.77,
95%CI=1.55,2.03,p<.0001), 4-9 visits (OR=3.34, 95%CI=3.23,3.44, p<.0001), 10-12 visits
(OR=3.99, 95%CI=3.83,4.15, p<.0001) and 13 or more visits (OR=3.28, 95%CI=2.93,3.67,
p<.0001). In the multivariable model, having DM was correlated with increased doctor visits,
ranging from 2-3 visits (OR=1.40, 95%CI=1.26,1.55, p<.0001), 4-9 visits (OR=2.06,
95%CI=1.88,2.27, p<.0001), 10-12 visits (OR=2.12, 95%CI=1.96,2.29, p<.0001) and 13 or more
visits (OR=1.83, 95%CI=1.61,2.08, p<.0001). Compared to males, females had lower odds of
having DM in both the bivariate (OR=0.83, 95%CI=0.78,0.89, p<.0001) and multivariable
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(OR=0.72, 95%CI=0.67,0.76, p=.02) models. Average health condition was associated with
decreased odds of having DM, compared to those of poor health condition in both the bivariate
(OR=2.79, 95%CI=2.51,3.11) and multivariable (OR=2.45, 95%CI=2.22,2.71) models. Those
who considered themselves in good or excellent condition had very low odds of having DM,
compared to those in poor health condition in both the bivariate (OR=6.52, 95%CI=5.68,7.48)
and multivariable (OR=4.82, 95%CI=4.26,5.45) models.
Descriptive Statistics for DM Diagnosis
Table 4.5 includes descriptive statistics of the study variables by DM diagnosis before
and after the ACA. The prevalence of undiagnosed DM patients was less (21.32%) than before
the ACA (26.73%). In the Pre ACA period, 75.91% of diagnosed patients were insured,
compared to 81.03% in the Post ACA period. Of diagnosed patients in the Pre ACA period,
43.2% had less than a high education, 45.8% had a high school education, and 10.8% had a
college education or higher. The distribution of education among properly diagnosed patients
post ACA changed slightly, with 33.7%, 49.8%, and 16.8%, respectively. Post ACA, utilization
increased overall, with 96.5% of those with properly diagnosed DM had at least 1 doctors visit,
compared to 96.2% Pre ACA. 82.3% of Medicaid/Medigap patients were properly diagnosed
after the ACA, compared to only 80.1% before.75.6% of those on Medicare were properly
diagnosed before the ACA, compared to 84.8% after the ACA. Before the ACA, 76.6% of those
with a USC were properly diagnosed, compared to 80.8% Post ACA. Before the ACA, only
71.5% percent of males had properly diagnosed DM, compared to 80.9% Post ACA. 77.2% of
Blacks, 78.2% of Hispanics, 84.34% of Whites, and 71.3% of other ethnicity had properly
diagnosed DM after the ACA, compared to 74.5%, 71.0%, 74.3%, and 73.3% Pre ACA,

17

respectively. Post ACA, 78.0% of those below the poverty line had properly diagnosed DM,
compared to 73.8% before.
Associations with undiagnosed DM
Table 4.6 contains the final multivariable multilevel model of an indicator of properly
diagnosed DM with selected covariates. Utilization of at least one doctors visit was significantly
related to proper DM diagnosis in a bivariate model(p<.0001), but this effect became
insignificant in the multivariable model (for 1 visit, OR=2.19, 95%CI=1.63,2.94, p=.31). In a
bivariate model, USC was related to proper DM diagnosis(OR=4.6, 95%CI=3.5,6.05, p<.0001),
but in a multivariable model USC was not associated with correct DM diagnosis(OR=1.64,
95%CI=1.09,2.48, p =.07). In a bivariate model, insurance was not significantly associated with
correct DM diagnosis (OR=1.92,95%CI=0.97,1.26, p=.06), and the association remained
insignificant in a multivariable model (OR=2.76, 95%CI=2.3,3.81, p=.34). In a bivariate model,
Medicaid/Medigap (OR=1.52, 95%CI=1.14,2.02), Medicare (OR=1.37, 95%CI=1.17,1.60), No
Insurance (OR=0.65, 95%CI=0.53,0.79) and other forms of insurance (OR=1.44,
95%CI=1.25,1.65) were significantly associated with having correctly diagnosed DM, compared
to those on private insurance(p<.0001). In the multivariable model, no particular type of
insurance is associated with having correctly diagnosed DM(p=.69). In a bivariate model,
good/excellent health condition (OR=2.9, 95%CI=2.4,3.5) and average health condition
(OR=1.6, 95%CI=1.37,1.85) were associated with correct DM diagnosis, compared to those in
poor health condition(p<.0001). However, in a multivariable model, this relationship did not
hold, and good/excellent health condition (OR=2.42, 95%CI=1.88,3.11) and average health
condition (OR=1.38, 95%CI=1.11,1.71) were not found to be associated to correct DM
diagnosis, compared to poor health condition(p=.06).
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We failed to find an association between income and missed patient status. There was no
significant association in a bivariate model (OR=1.02, p=.82) and income was not included in the
multivariable model. In a bivariate model, education was not found to be associated with
properly diagnosed DM (OR=1.11, 95%CI=0.97,1.26, p=.06). In a bivariate model, sex was not
significant (OR=0.96, 0.71,1.17, p=.69). In a bivariate model, Black (OR=0.84,
95%CI=0.67,1.06), Hispanic (OR=0.79, 95%CI=0.61,1.02), and Other ethnicity (OR=0.68,
95%CI=0.47,0.97) were significantly related to correctly diagnosed DM, compared to those of
White ethnicity (p=.05). However, in a multivariable model, no other ethnicity was associated
with correctly diagnosed DM, when compared to those of White ethnicity (p-value=.41).
Individuals were more likely to have their DM properly diagnosed after the ACA, as
opposed to before. In a bivariate model, the period after the ACA was significantly associated
(OR=1.34, 95%CI=1.10,1.64, p=.003) with proper DM diagnosis. In a multivariable model
adjusted for Time Period, Utilization, USC, Health Condition, Insurance, Ethnicity, and
Insurance Type, only time period was related to correctly diagnosed DM. Those in the period
after the ACA were more likely (OR=1.51, 95%CI=1.24,1.85, p=.04) to have properly diagnosed
DM, when compared to those in the time period before the ACA was passed.
Discussion
Controlling for demographic characteristics, the association between insurance status and
DM has not changed since the passage of the ACA. Those with insurance were still much more
likely to have DM. A possible explanation for this finding is that many of the uninsured are
young or in good health and do not feel pressure to purchase health insurance. DM prevalence
also increases with age. In this sample, those with insurance are, on average, 11 years older than
those without. Using only the NHANES dataset, it is not possible to determine the effect of
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insurance on the development of DM. A longitudinal study that follows individuals over time
could determine whether those who have insurance are less likely to develop DM in the future.
There have not been any studies of this type conducted in the period after the ACA.
The association between healthcare utilization and DM have not changed since the
passage of the ACA. While a single yearly doctor’s visit was not significantly associated with
having DM, it did significantly decrease the odds of being a missed patient. While this
association has not been studied in among those who are undiagnosed with diabetes, a failure to
receive annual Primary Care visits has been found to be associated with poorer outcomes and
increased hospitalizations due to DM[65]. Although utilization above 2 visits was associated
with an increased chance of having DM, this is expected due to more frequent doctor’s visits by
diabetics. Diabetics, particularly those with a formal diagnosis, tend to have a much higher
frequency of physician visits than those without DM[66]. Controlling for previous diagnosis
might be a way to further explore this relationship. Future studies analyzing utilization should
consider if subjects have a DM diagnosis.
Having a USC and level of health services utilization do seem to be linked. Those with a
USC generally had much higher utilization rates. However, it is still unclear if there is a causal
pathway between USC and utilization. Like previous studies suggested, having a USC was more
strongly related to having properly diagnosed diabetes than having health insurance [31, 34].
This could be due to the fact that many who are insured have high copays and do not visit the
doctor enough to establish a USC. This would explain the lower diagnosis rates.
A higher percentage of subjects had some form of health insurance after the ACA,
compared to before. This implies that the legislation may have actually led to increased
healthcare coverage, as it was intended to. Those without health insurance were much more
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likely to be a missed patient, compared to those with any type of health insurance. If the trend of
expanded healthcare coverage in the population continues, the prevalence of missed patients
should continue to decrease.
Those without insurance were less likely to go to the doctor or have a USC. We did not
find evidence to support some earlier studies. Earlier studies found those that a USC alone
improved access and outcomes, but the effect on DM diagnosis rates due to a USC was
negligible [31]. The link between these factors and being a missed patient had not been
previously studied. Although insurance, USC, and utilization all independently influenced
missed patient status, none were found to be significant in an adjusted model.
Before the ACA, those on Medicaid/Medigap were less likely to be missed patients than
those with private health insurance. After the ACA, there was no perceptible increase in
likelihood of having DM properly diagnosed. This contradicts the idea and previous evidence
that Medicaid expansion lead to better care and more healthcare attention paid to vulnerable
populations[67]. The failure of Medicaid expansion in some states and changes in funding could
be responsible for this effect[68]. Although the geographical data collected by NHANES is
restricted, study of the differences in missed patients and DM outcomes between Expansion and
Non-Expansion states or different state-level policies could be informative. This would allow for
a more specific assessment of policies.
While we did not find any significant effects due to income other than in the bivariate
model for DM, prior studies have found lower income to be associated with a greater probability
of developing DM[18]. This could be because the binary indicator for income did not contain
enough information to capture these differences or that there truly is no effect, particularly when
other characteristics are accounted for.
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There were significant disparities and differences in outcomes between races. Compared
to whites, ethnic minorities were more likely to qualify as a missed patient after the passage of
the ACA. While ethnic minority changes in missed patient status after the ACA has not been
studied, a 2016 study found that access for minorities had increased overall[69]. There is no
research concerning Diabetes outcomes for ethnic and racial minorities in the period after the
ACA. Future studies should place an increased focus on outcomes for minorities. Poorer
outcomes for minorities are a common finding in this study, and targeted interventions are
needed.
While this sample does not show a significant difference in DM prevalence between the
two time-periods, other estimates show that the overall prevalence of DM increased after the
ACA[1]. Chronic diseases have long latent periods, and it is not realistic to expect any noticeable
decrease or change in DM occurrence over such a short time period. The increased prevalence of
DM should not be taken as an indicator that the ACA has been ineffective or has somehow
contributed to DM cases.
Controlling for all other relevant factors, ACA time-period was the only significant
effect, meaning that the time After the ACA was the only factor related to a patient receiving a
correct DM diagnosis. After the passage of the ACA, patients had lower odds of being a missed
patient than before the ACA, signifying that the ACA may have had a positive effect on
awareness of DM and willingness of physicians to screen for DM, even if the prevalence is
increasing. This effect has not been studied before and is an important piece of evidence in
determining if the ACA has generated a tangible change in DM diagnosis.
Methodological Limitations
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While some research exists concerning other biological measures, there have been no
studies concerning the validity of the HbA1c results from NHANES[70]. Past studies have found
that certain biological markers, particularly caloric data, measured by NHANES do not have
good predictive validity[70]. However, since HbA1c is considered the gold standard for a singlevisit diagnosis of diabetes and past studies have found that DM can be accurately diagnosed from
HbA1c data, it is reasonable to assume those measurements can be used to predict the presence
or absence of DM. However, the validity of the NHANES HbA1c values are another matter
entirely. A 2003 study found that data collected by the survey on blood lead levels suffered from
widespread methodological errors and failed to approximate the actual population distribution
levels of lead[71]. While there have been changes in the survey methodology since that time,
there has been no research on how those changes may have led to better validity.
Generalizing findings from analyses of NHANES biomarker data is common in the
literature, but needs further study to ensure that it is valid to do so[72]. NHANES also does not
select participants from nursing homes, the armed forces, prisons, or those living abroad[4]. As
these groups make up a significant proportion of the population and ignoring them could lead to
a lack of generalizability.
There are also possible measurement issues. While HbA1c values should not be subject
to bias, not all survey participants are tested and there may be significant differences between
those tested and those who are not. The methods behind which subjects are tested and why are
not made clear by the survey, and there is no ‘refused to participate’ or ‘not selected to
participate’ categories in the laboratory data. NHANES does not provide any information or
documentation on which participants are selected for blood testing. The particular wording of the
survey questions could also lead to systematic bias, particularly if wording leads the participant
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to believe that one response is more desirable than the other, and the self-reported nature of the
diagnosis questions and much of the healthcare behavior data could be subject to widespread
inaccuracy. Primary issues in the questionnaire for this study include recall bias and
unacceptability of a given response. [73] Whether or not a patient has been diagnosed with DM
is not verified and based only on the response to a single question.
Statistical Limitations
Using retrospective data makes it difficult to establish causality. Future studies could use
propensity scores and matching to determine causality, rather than just an association.
Prospective studies could also establish causality.
A limitation of the GEE method is that all missing values must be assumed to be missing
completely at random(MCAR). Since there was a low frequency of missing data, and the missing
values seemed to be evenly distributed and unassociated with any single category, the results
should not have been significantly affected. Survey weights were not accounted for. Although
some studies have found that discounting survey weights does not have inferential consequences,
it still would have been preferable to include them.
Conclusions
Since the trends in DM are unlikely to change without massive, societal-level changes,
focusing on strategies to prevent missed patients seems like a realistic policy focus. Identifying
populations at risk of being missed patients and focusing efforts and programs in their direction
will lead to earlier diagnosis and less complications and costs from the disease. Utilization, USC,
and Insurance would be the best focuses for an intervention, as these are factors that can be
influenced, unlike demographics. Physicians should be aware of factors that predispose a patient
to having undiagnosed DM (non-white ethnicity, lower level of education, older age, being
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uninsured, lack of a USC) and take steps to see if undiagnosed DM could be possible. Patients
should be more regularly screened for DM. Increasing insurance coverage and encouraging
regular doctor visits could seriously decrease the amount of undiagnosed cases of DM and the
associated burden of care.
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Table 4.1: Descriptive statistics of socio-demographic, health behavior, and DM study
variables.
PRE ACA
Count (%)
15612(50.00%)

POST ACA
Count (%)
15613(50.00%)

TOTAL
Count (%)
31225(100%)

No
Yes
Missing

13513(20.08%)
1801(11.54%)
298(1.91%)

13105(83.94%)
2109(13.50%)
399(2.56%)

26618(85.25%)
3910(12.52%)
697(2.23%)

No
Yes
Missing

3740(23.95%)
11861(75.97%)
11(0.07%)

3231(20.69%)
12363(79.18%)
19(0.12%)

6971(22.33%)
24224(77.59%)
30(0.09%)

4541(29.09%)

3548(22.72%)

8089(25.91%)

7963(51.01%)
3086(19.77%)
22(0.14%)

8123(52.03%)
3932(25.18%)
10(0.06%)

16086(51.52%)
7018(22.48%)
32(0.10%)

2590(16.58%)
2697(17.28%)
4075(26.10%)
3922(25.12%)
1096(7.02%)
1220(7.81%)
12(0.08%)

2567(16.44%)
2795(17.90%)
4379(28.05%)
3890(24.92%)
916(5.87%)
1050(6.73%)
16(0.10%)

5157(16.52%)
5492(17.59%)
8454(27.07%)
7812(25.02%)
2012(6.44%)
2270(7.27%)
28(0.09%)

13968(89.47%)
1644(10.53%)

13714(87.84%)
1899(12.16%)

27682(88.65%)
3543(11.35%)

1223(7.83%)
2812(18.01%)
3742(23.96%)
1743(11.16%)
6058(38.80%)
34(0.22%)

1784(11.43%)
2376(15.22%)
3239(20.75%)
2232(14.30%)
5902(37.80%)
80(0.51%)

3007(9.63%)
5188(16.61%)
6981(22.36%)
3975(12.73%)
11960(38.30%)
114(0.37%)

2391(15.32%)
13221(84.68%)
0

2542(16.28%)
13071(83.72%)
0

4933(15.80%)
26292(84.02%)
0

6267(40.14%)
5521(35.36%)
3815(24.45%)

6018(38.54%)
5839(37.40%)
3742(23.96%)

12885(39.37%)
11360(36.41%)
7557(24.22%)

Variable
Diagnosis

Insured

Education
Less than High
School
High School Grad
College Graduate
Missing
Utilization
0
1
2-3
4-9
10-12
>13
Missing
Diabetes
No
Yes
Insurance Type
Medicaid/Medigap
Medicare
None
Other
Private
Missing
Usual Source of Care
No
Yes
Missing
Health Condition
Poor/Fair
Average
Good/Excellent
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Missing

9(0.06%)

14(0.09%)

23(0.07%)

Female
Male
Missing

8057(51.61%)
7555(48.39%)
0

8068(51.67%)
7545(48.33%)
0

16125(51.64%)
15100(48.36%)
0

Black
Hispanic
White
Other
Missing

3017(19.32%)
4235(27.13%)
7641(48.94%)
719(4.61%)
0

3432(21.98%)
3828(24.52%)
5942(38.06%)
2411(15.44%)
0

6449(20.65%)
8063(25.82%)
13583(43.50%)
3130(10.02%)
0

Income
Below Poverty Line
Above Poverty Line
Missing

2852(18.27%)
11439(73.27%)
1321(8.46%)

3219(20.62%)
10939(70.06%)
1455(9.32%)

6071(19.44%)
22378(71.67%)
2776(8.89%)

Mean (SD)
49.5 (18.2)

Mean (SD)
49.1 (17.7)

Mean (SD)
49.3 (17.9)

Sex

Ethnicity

Age

*Missing values included those who responded ‘Don’t Know’ or ‘Refuse to Answer’
Definitions: ACA- Affordable Care Act, SD- Standard Deviation, DM- Diabetes Mellitus
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Table 4.2: Multilevel marginal model regression coefficient estimates (p-values) for DM status with selected covariates (n=31,225)+.
Variable
Fixed intercept

Model 1

Model 2

Model 3

Model 4

Model 5

-4.39 (.01)

-4.47 (.01)

-4.41 (.01)

-5.10 (.002)

-5.21 (.002)

0.02(.01)

0.22(.01)

0.22(.01)

0.21(.002)

0.04(<.0001)

0.04(<.0001)

0.04(<.0001)

0.03(<.0001)

Model 6

Model 7

Model 8

-4.96 (.001)

-4.94 (.01)

-4.99 (.003)

0.22(.002)

0.23(.001)

0.15(.01)

0.17(.003)

0.04(<.0001)

0.04(<.0001)

0.04(<.0001)

0.04(<.0001)

-0.17(<.0001) -0.25(<.0001) -0.25(<.0001) -0.27(<.0001) -0.28(<.0001) -0.29(<.0001) -0.31(<.0001)

-0.33(<.0001)

Affordable Care Act
After v. Before
Age
(in years)
Sex(p-value)
Female v. Male
Utilization(p-value)
1 visit v. no visits

-0.08(<.0001) -0.11(<.0001) -0.02(<.0001)

0.01(<.0001)

0.02(<.0001)

0.02(<.0001)

0.03(<.0001)

2-3 Visits v. no visits

0.26(<.0001)

0.22(<.0001)

0.23(<.0001)

0.26(<.0001)

0.28(<.0001)

0.30(<.0001)

0.34(<.0001)

4-9 Visits v. no visits

0.74(<.0001)

0.70(<.0001)

0.55(<.0001)

0.60(<.0001)

0.62(<.0001)

0.68(<.0001)

0.72(<.0001)

10-12 Visits v. no visits

0.92(<.0001)

0.88(<.0001)

0.58(<.0001)

0.63(<.0001)

0.65(<.0001)

0.72(<.0001)

0.75(<.0001)

>13 Visits v. no visits

0.77(<.0001)

0.73(<.0001)

0.36(<.0001)

0.42(<.0001)

0.45(<.0001)

0.56(<.0001)

0.61(<.0001)

-0.01(.29)

-0.20(.01)

-0.25(.004)

-0.26(.003)

-0.25(.004)

-0.25(.03)

Good/Excellent v. Poor/Fair

1.17(<.0001)

1.60(<.0001)

1.50(<.0001)

1.39(<.0001)

1.42(<.0001)

Average v. Poor/Fair

0.94(<.0001)

0.93(<.0001)

0.88(<.0001)

0.81(<.0001)

0.83(<.0001)

0.17(<.0001)

0.13(.001)

0.09(.01)

0.14(<.0001)

High School v. Less than High School

-0.12(<.0001)

-0.006(.05)

-0.02(.07)

College Graduate v. Less than High School

-0.36(<.0001)

-0.23(.05)

-0.23(.07)

Usual Source of Care
No v Yes
Health condition

Insurance
No v. Yes
Education

Ethnicity
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Black v Other

0.05(<.0001)

0.07(<.0001)

Hispanic v Other

-0.02(<.0001)

0.019(<.0001)

White v Other

-0.68(<.0001)

-0.61(<.0001)

Income
Above Poverty Line v. Below
QIC

-0.03(.62)
20416.35

20074.16

20075.70

19036.59

19010.63

18957.36

18690.69

16774.19

+

Based on QIC, model 8 was selected
Smaller QIC values indicate a better fitting model
*Definitions: QIC- Quasi-Information Criterion, ACA- Affordable Care Act, CI- Confidence Interval, OR- Odds Ratio,

DM- Diabetes Mellitus
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Table 4.3: Model comparisons across correlation structures*.

Variable
Intercept
Affordable Care Act
After v. Before
Age
(in years)
Sex
Female v. Male
Utilization
1 visit v. no visits
2-3 Visits v. no visits
4-9 Visits v. no visits
10-12 Visits v. no visits
>13 Visits v. no visits
Usual Source of Care
No v Yes
Health condition
Good/Excellent v. Poor/Fair
Average v. Poor/Fair
Insurance
No v. Yes
Education
High School v. Less than High
School
College Graduate v. Less than High
School
Ethnicity
Black v Other
Hispanic v Other
White v Other
Income
Above Poverty Line v. Below
QICµ

Independence
Estimate(p-value)
-4.99(<.0001)

First-order
Autoregressive
Estimate(p-value)
-3.04(<.0001)

Compound
Symmetry
Estimate(p-value)
-4.99(<.0001)

0.17(.003)

0.23(.05)

0.17(.003)

0.04(<.0001)

0.02(<.0001)

0.04(<.0001)

-0.33(<.0001)

-0.23(<.0001)

-0.34(<.0001)

0.03(.53)
0.33(<.0001)
0.72(<.0001)
0.75(<.0001)
0.60(<.0001)

0.03(.15)
.21(<.0001)
0.49(<.0001)
0.53(<.0001)
0.42(<.0001)

0.03(.54)
0.33(<.0001)
0.72(<.0001)
0.75(<.0001)
0.60(<.0001)

-0.24(.03)

-0.14(.002)

-0.25(.03)

1.41(<.0001)
0.83(<.0001)

0.93(<.0001)
0.47(<.0001)

1.41(<.0001)
0.83(<.0001)

0.14(<.0001)

0.06(<.0001)

0.14(<.0001)

-0.02(.38)

-0.04(.01)

-0.02(.38)

-0.23(.03)

-0.17(.001)

-0.23(.03)

0.07(.31)
0.02(.71)
-0.61(<.0001)

0.06(.16)
0.004(.89)
-0.41(<.0001)

0.08(.30)
0.02(.68)
-0.61(<.0001)

-0.03(.62)
16773.27

-0.03(.50)
19399.92

-0.03(.63)
16773.28

*

Based on QICµ, an Independent correlation structure was chosen for the final model
Smaller QIC values indicate a better fitting model
Definitions: QIC- Quasi-Information Criterion, ACA- Affordable Care Act, USC- Usual Source of Care, DMDiabetes Mellitus
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Table 4.4: Final multivariable multilevel marginal model for the association between DM status
with selected covariates (n=31225).
Bivariate

Variable

Unadjusted OR(95%CI)
ACA

Multivariable
p-value

Adjusted OR (95%CI)

p-value

.07
After
Before

1.77(0.99,1.40)
Reference

Female
Male

0.83(0.78,0.89)
Reference

Sex

.09
1.90(1.06,1.33)
Reference

<.0001

.02
0.72(0.67,0.76)
Reference

Utilization

<.0001
.31
No Visits
Reference
Reference
1 Visit
1.03(0.99,1.07)
1.03(0.93,1.14)
2-3 Visits
1.77(1.55,2.03)
1.40(1.26,1.55)
4-9 Visits
3.34 (3.23,3.44)
2.06(1.88,2.27)
10-12 Visits
3.99 (3.83,4.15)
2.12(1.96,2.29)
>13 Visits
3.28(2.93,3.67)
1.83(1.61,2.08)
Usual Source of Care
<.0001
.03
No
Reference
Reference
Yes
2.37(2.07,2.73)
1.28(1.03,1.59)
Health condition
<.0001
.05
Good/Excellent
6.52(5.68,7.48)
4.82(4.26,5.45)
Average
2.79(2.51,3.11)
2.45(2.22,2.71)
Poor/Fair
Reference
Reference
Insurance
<.0001
.02
No
Reference
Reference
Yes
1.51(1.44,1.58)
1.21(1.17,1.26)
Education
<.0001
.05
College Graduate
0.39(0.36,0.42)
0.79(0.64,0.97)
High School Graduate
0.60(0.58,0.68)
0.97(0.93,1.03)
Less than High School
Reference
Reference
Ethnicity
<.0001
.11
Black
1.88(1.63,2.16)
1.88(1.68,2.12)
Hispanic
1.72(1.52,1.97)
1.99(1.75,2.26)
Other
1.35(1.18,1.56)
1.85(1.66,2.05)
White
Reference
Reference
Income
.0007
.28
Above Poverty Line
0.76(0.65,0.89)
0.97(0.86,1.10)
Below Poverty Line
Reference
Reference
Insurance Type
<.0001
Medicaid/Medigap
2.17(1.86,2.53)
Medicare
2.79(2.64,2.96)
None
1.05(0.96,1.14)
Other
1.50(1.31,1.70)
Private
Reference
A Marginal Model with Generalized Estimating Equations was used to account for clustering within year;
probability of Diabetes is modeled
ǂWald 𝜒 2 test, at α=0.05
Missing Data: Diagnosis (N=697), Insurance (N=30), Education (N=32), Utilization (N=28), Diabetes (N=0),
Insurance Type (N=114), USC (N=0), Health Condition (N=23), Sex (N=0), Ethnicity (N=0), Income
(N=2776), Age (N=0)
Definitions: ACA- Affordable Care Act, CI- Confidence Interval, OR- Odds Ratio, DM- Diabetes Mellitus
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Table 4.5: Descriptive statistics of study variables by DM diagnosis before and after the ACA
(n=3394).
PRE ACA
POST ACA
n= 1579
n= 1815
Diagnosed
Yes
No
1157(73.27%)
422(26.73%)

Variable
Insured
No
Yes
Education
Less than High School
High School
College Graduate
Utilization
0
1
2-3
4-9
10-12
>13
Insurance Type
Medicaid/Medigap
Medicare
None
Other
Private
Usual Source of Care
No
Yes
Health Condition
Poor/Fair
Average
Good/Excellent
Sex
Female
Male
Ethnicity
Black
Hispanic
Other
White

Diagnosed
Yes
No
1428(78.68%)
387(21.32%)

184(64.79%)
973(75.91%)

100(35.21%)
321(24.81%)

183(65.83%)
1243(81.03%)

95(34.17%)
291(18.97%)

500(74.18%)
530(72.11%)
125(74.50%)

174(25.82%)
205(27.89%)
43(25.60%)

481(78.59%)
704(78.57%)
240(79.21%)

131(21.41%)
192(21.43%)
63(20.79%)

41(31.78%)
60(45.45%)
258(73.30%)
469(80.72%)
160(82.05%)
167(88.83%)

88(68.22%)
72(54.55%)
94(26.70%)
112(19.28%)
35(17.95%)
21(11.17%)

54(36.00%)
104(61.18%)
350(81.59%)
592(85.55%)
162(87.10%)
164(88.17%)

96(64.00%)
66(38.82%)
79(14.45%)
100(12.90%)
24(12.90%)
22(11.83%)

151(80.32%)
384(75.59%)
184(64.79%)
297(70.88%)
140(80.00%)

37(19.68%)
124(24.41%)
100(35.21%)
122(29.12%)
35(20.00%)

232(82.27%)
397(84.47%)
184(65.71%)
388(77.29%)
223(81.09%)

50(17.73%)
73(15.53%)
96(34.29%)
114(22.71%)
52(18.91%)

46(35.94%)
1111(76.57%)

82(64.06%)
340(23.43%)

72(54.94%)
1356(80.76%)

64(47.06%)
323(19.24%)

153(61.20%)
366(68.67%)
637(80.13%)

97(38.80%)
167(31.33%)
158(19.87%)

165(63.71%)
513(75.78%)
749(85.31%)

94(36.29%)
164(24.22%)
129(14.69%)

574(75.23%)
583(71.45%)

189(24.77%)
233(28.55%)

656(76.28%)
772(80.84%)

204(23.72%)
183(19.16%)

316(74.53%)
359(71.09%)
55(73.33%)
427(74.26%)

108(25.47%)
146(29.91%)
20(26.67%)
148(25.74%)

376(77.21%)
437(78.18%)
184(71.32%)
431(84.34%)

111(22.79%)
122(21.82%)
74(28.68%)
80(15.66%)

786(72.58%)

297(27.42%)

909(78.84%)

244(21.16%)

Income
Above Poverty Line

Below Poverty Line
239(73.77%)
85(26.23%)
364(77.94%)
103(22.06%)
Missing Data: Insurance(n=4), Insurance Type(n=10), Education (N=6), Utilization (N=4), Usual Source
of Care (N=0), Health Condition (N=2), Sex (N=0), Ethnicity (N=0), Income (N=367)
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Table 4.6: Final multivariable multilevel marginal model of an indicator of properly diagnosed DM with
selected covariates (n=3394).
Bivariate
Multivariable
Variable
Unadjusted
OR(95%CI)
ACA

p-valueǂ

Adjusted OR (95%CI)

p-valueǂ

.003
After
Before

1.34 (1.10,1.64)
Reference

Sex

.04
1.51(1.24,1.85)
Reference

.69
Female
Male

0.96 (0.71,1.17)
Reference

Utilization

<.0001
No Visits
Reference
Reference
1 Visit
2.30(1.82,2.90)
2.19(1.63,2.94)
2-3 Visits
1.77(1.55,2.03)
5.99(4.82,7.47)
4-9 Visits
9.69(8.30,11.32)
8.16(7.03,9.47)
10-12 Visits
10.57(8.69,12.86)
8.31(7.06,9.79)
>13 Visits
14.90(10.91,20.37)
10.72(8.55,13.45)
Usual Source of Care
<.0001
No
Reference
Reference
Yes
4.60(3.50,6.05)
1.64(1.09,2.48)
Health condition
<.0001
Good/Excellent
2.90(2.40,3.50)
2.42(1.88,3.11)
Average
1.60(1.37,1.85)
1.38(1.11,1.71)
Poor/Fair
Reference
Reference
Insurance
<.0001
No
Reference
Reference
Yes
1.92(1.59,2.33)
2.76(2.30,3.81)
Education
.06
College Graduate
1.11(0.97,1.26)
High School Graduate
1.03(0.87,1.14)
Less than High School
Reference
Ethnicity
.05
Black
0.84(0.67,1.06)
0.78(0.60,1.00)
Hispanic
0.79(0.61,1.02)
0.89(0.64,1.25)
Other
0.68(0.47,0.97)
0.75(0.55,1.03)
White
Reference
Reference
Income
.82
Above Poverty Line
1.02(0.84,1.25)
Below Poverty Line
Reference
Insurance Type
<.0001
Medicaid/Medigap
1.52(1.14,2.02)
0.85(0.63,1.16)
Medicare
1.37(1.17,1.60)
0.99(0.82,1.21)
None
0.65(0.53,0.79)
0.39(0.32,0.48)
Other
1.44(1.25,1.65)
1.02(0.93,1.14)
Private
Reference
Reference
A Marginal Model with Generalized Estimating Equations was used to account for clustering within year;
probability modeled was whether diabetic subjects had a proper diabetes diagnosis
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.31

.07

.06

.34

.41

.69

ǂ

Wald 𝜒 2 test, at α=0.05
Missing Data: Insurance(n=4), Insurance Type(n=10), Education (n=6), Utilization (n=4), Usual Source of
Care (n=0), Health Condition (n=2), Sex (n=0), Ethnicity (n=0), Income (n=367)
Definitions: ACA- Affordable Care Act, CI- Confidence Interval, OR- Odds Ratio, DM- Diabetes Mellitus
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